share_log

Benchmark Downgrades VolitionRX to Hold

Benzinga Real-time News ·  Feb 1, 2023 07:18

Benchmark analyst Bruce Jackson downgrades VolitionRX (AMEX:VNRX) from Buy to Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment